BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3501855)

  • 1. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
    Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
    Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
    Kumagai N; Benedict SH; Mills GB; Gelfand EW
    J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
    Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
    J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling of c-myc mRNA expression from G1 events in human T lymphocytes.
    Friedrich B; Gullberg M; Lundgren E
    Anticancer Res; 1988; 8(1):23-8. PubMed ID: 3128958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
    Farrar WL; Evans SW; Rapp UR; Cleveland JL
    J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.
    Schneider-Schaulies J; Hünig T; Schimpl A; Wecker E
    Eur J Immunol; 1986 Mar; 16(3):312-6. PubMed ID: 3514240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
    Heckford SE; Gelmann EP; Matis LA
    Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J; Cusmano G; Introna M
    J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
    Buckler AJ; Vie H; Sonenshein GE; Miller RA
    J Immunol; 1988 Apr; 140(7):2442-6. PubMed ID: 3280682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of c-fos and c-myc mRNA levels in normal human lymphocytes by calcium ionophore A23187 and phorbol ester.
    Grausz JD; Fradelizi D; Dautry F; Monier R; Lehn P
    Eur J Immunol; 1986 Oct; 16(10):1217-21. PubMed ID: 3095123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of T lymphocytes by the v-fos oncogene.
    Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
    J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines.
    Tsuda H; Aso N; Sawada T; Hata H; Kawakita M; Mori KJ; Takatsuki K
    Int J Cell Cloning; 1991 Mar; 9(2):123-33. PubMed ID: 2037810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12-induced activation of NK and T cells occurs in the absence of immediate-early activation gene expression.
    Azzoni L; Kanakaraj P; Zatsepina O; Perussia B
    J Immunol; 1996 Oct; 157(8):3235-41. PubMed ID: 8871617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of c-fos and c-myc expression in T lymphocytes after treatment with recombinant interleukin 1-alpha.
    Kovacs EJ; Oppenheim JJ; Young HA
    J Immunol; 1986 Dec; 137(11):3649-51. PubMed ID: 3537122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.